Is OZ Minerals Limited still a buy on profit result?

OZ Minerals Limited (ASX:OZL) has reported a flat interim profit result today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Copper and gold producer OZ Minerals Limited (ASX: OZL) has reported a 3% increase in underlying profits for the six months ending June 30.

Here are the key takeaways from the ASX announcement:

  • Revenue up 8% to $398 million
  • Underlying earnings before interest and tax (EBIT) up 1.1% to $76 million
  • Underlying net profit after tax (NPAT) up 3% to $55 million
  • Underlying earnings per share up 1% to 18.1 cents per share (cps)
  • Dividend declared of 6 cps. OZ Minerals' shares will trade ex-dividend on September 8 with payment on September 23
  • Cash at bank up 11% to $564 million with no debt
  • Copper of 58,368 tonnes and gold of 57,662 ounces was produced

What's next:

Management noted that momentum continues to build across the company with the group's Carrapateena asset on schedule to deliver first concentrate in the second half of 2019.

With a keen focus on creating a lean cost structure with reduced corporate overheads and reduced operating costs, management has stated that OZ Minerals is positioned as one of the lowest operating cost copper producers in the world.

With a market capitalisation of around $2 billion, OZ Minerals is one of the larger exposures to copper producers available to investors on the ASX, with exposure to gold as well.

For the full year, Oz Minerals expects to produce between 115,000 and 125,000 tonnes of contained copper, but financial results remain highly dependent on where the copper price goes – and that doesn't appear to be positive. Goldman Sachs recently predicted a 17% fall in copper prices – despite the huge falls already experienced in the past year or so.

Given that, Oz Minerals doesn't appear to be the bargain buy investors might think.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »